Abstract
Rhesus incompatibility between mother and foetus can, if undetected and untreated, lead to Rhesus disease of the newborn: a haemolytic state which can be fatal. Screening in pregnancy allows routine prevention of Rhesus disease. Post-delivery administration of anti-D immunoglobulin to Rhesus-negative women began in the UK in 1969. As a result, the deaths attributed to RhD alloimmunization fell from 46/100 000 births before 1969 to 1.6/100000 in 1990. However, antenatal procedures and presentations commonly encountered in primary care may cause the exposure of a Rhesus-negative mother to Rhesus antigens. Awareness of Rhesus disease in routine and emergency antenatal care is therefore essential.
Get full access to this article
View all access options for this article.
